The National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) is the largest BRC outside the South East of England and the beating heart of translational research across Greater Manchester, Lancashire and South Cumbria, transforming scientific breakthroughs into diagnostic tests and life-saving treatments for patients.
Awarded more than £60 million (2022-27) – the largest single research award given by the NIHR to the city region – Manchester BRC brings together world-leading researchers based at The University of Manchester and six of the country’s foremost NHS Trusts, with a vision to drive health improvements and lasting change for all through creative, inclusive and proactive research that identifies and bridges gaps between new discoveries and individualised care.
Manchester BRC is driving forward pioneering research in the areas of cancer (prevention and early detection, advanced radiotherapy, precision medicine, living with and beyond cancer), inflammation (rheumatic and musculoskeletal disease, respiratory medicine, dermatology, integrative cardiovascular medicine), high-burden under-researched conditions (hearing health, mental health, rare conditions) and disease complexity and multimorbidity (next generation phenotyping and diagnostics, next generation therapeutics).
The 'Team Womb' collective based at Manchester University NHS Foundation Trust and The University of Manchester, supported by the NIHR Manchester Biomedical Research Centre, have been awarded a prestigious American Association for Cancer Research Award.
Scientists have found genes expressed in human cells harvested from urine are remarkably similar to those of the kidney itself, suggesting they could be an important non-invasive source of information on the kidney.
There are plently of opportunities for people to help shape our research plans.
Research is vital to help us understand more about a particular disease or condition and how to treat them.